within Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AF04_Eslicarbazepine;

model Eslicarbazepine
  extends Pharmacolibrary.Drugs.ATC.N.N03AF04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N03AF04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Eslicarbazepine is an anticonvulsant drug used primarily as adjunctive therapy for partial-onset seizures in adults with epilepsy. It is the active metabolite of eslicarbazepine acetate and acts mainly as a voltage-gated sodium channel blocker. Eslicarbazepine is approved in several countries, including under the trade name Zebinix or Aptiom.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers (mixed sex) after oral administration of eslicarbazepine acetate, reporting data for the active metabolite eslicarbazepine.</p><h4>References</h4><ol><li><p>Zaccara, G, &amp; Perucca, E (2014). Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. <i>Epileptic disorders : international epilepsy journal with videotape</i> 16(4) 409–431. DOI:<a href=\"https://doi.org/10.1684/epd.2014.0714\">10.1684/epd.2014.0714</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25515681/\">https://pubmed.ncbi.nlm.nih.gov/25515681</a></p></li><li><p> (2024). Comparison Table: Some oral antiseizure medications. <i>The Medical letter on drugs and therapeutics</i> 66(1708) e133–e140. DOI:<a href=\"https://doi.org/10.58347/tml.2024.1708b\">10.58347/tml.2024.1708b</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39073881/\">https://pubmed.ncbi.nlm.nih.gov/39073881</a></p></li><li><p>Schoretsanitis, G, et al., &amp; de Leon, J (2022). Drug-drug interactions between psychotropic medications and oral contraceptives. <i>Expert opinion on drug metabolism &amp; toxicology</i> 18(6) 395–411. DOI:<a href=\"https://doi.org/10.1080/17425255.2022.2106214\">10.1080/17425255.2022.2106214</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35876180/\">https://pubmed.ncbi.nlm.nih.gov/35876180</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Eslicarbazepine;
